DXN is trading 8.86% up at A$0.43 after investors reassessed its FY26 results and forward backlog.

  • FY26 revenue fell 33% to A$10.1 million following customer project deferrals.
  • Record backlog reached approximately A$40 million, with around 45% expected as 1H FY27 revenue; independent coverage also reported growth to A$40.9 million by August 30, 2026.